New Treatment Approved for Active SPMS MStranslate March 27, 2019 Research, Treatments 1 Comment It was announced earlier today that Mayzent (siponimod) has received US FDA approval for the treatment of adults living with relapsing multiple sclerosis (MS). Importantly, this also includes people living...
